Antiretroviral therapy in the developing world

被引：8

作者：

Chulamokha, L ^{[1
]}

DeSimone, JA ^{[1
]}

Pomerantz, RJ ^{[1
]}

机构：

[1] Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Div Infect Dis & Environm Med, Philadelphia, PA 19107 USA

来源：

JOURNAL OF NEUROVIROLOGY | 2005年 / 11卷

关键词：

acquired immunodeficiency syndrome; antiretroviral therapy; developing countries; HAART; HIV infection;

D O I：

10.1080/13550280590931270

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页码：76 / 80

页数：5

共 41 条

[1] Can highly active antiretroviral therapy reduce the spread of HIV?: A study in a township of South Africa [J].

Auvert, B ;

Males, S ;

Puren, A ;

Taljaard, D ;

Caraël, M ;

Williams, B .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 36 (01) :613-621

[2] Usefulness of total lymphocyte count in monitoring highly active antiretroviral therapy in resource-limited settings [J].

Badri, M ;

Wood, R .

AIDS, 2003, 17 (04) :541-545

[3] Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults [J].

Bartlett, JA ;

DeMasi, R ;

Quinn, J ;

Moxham, C ;

Rousseau, F .

AIDS, 2001, 15 (11) :1369-1377

[4]

CHURCHYARD G, 2004, C RETR OPP INF 2004

[5] REDUCTION OF MATERNAL-INFANT TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH ZIDOVUDINE TREATMENT [J].

CONNOR, EM ;

SPERLING, RS ;

GELBER, R ;

KISELEV, P ;

SCOTT, G ;

OSULLIVAN, MJ ;

VANDYKE, R ;

BEY, M ;

SHEARER, W ;

JACOBSON, RL ;

JIMENEZ, E ;

ONEILL, E ;

BAZIN, B ;

DELFRAISSY, JF ;

CULNANE, M ;

COOMBS, R ;

ELKINS, M ;

MOYE, J ;

STRATTON, P ;

BALSLEY, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (18) :1173-1180

[6]

Eshleman Susan H., 2002, AIDS Reviews, V4, P59

[7] Community-based approaches to HIV treatment in resource-poor settings [J].

Farmer, P ;

Léandre, F ;

Mukherjee, JS ;

Claude, MS ;

Nevil, P ;

Smith-Fawzi, MC ;

Koenig, SP ;

Castro, A ;

Becerra, MC ;

Sachs, J ;

Attaran, A ;

Kim, JY .

LANCET, 2001, 358 (9279) :404-409

[8] HIV type 1 diversity in France, 1999-2001: Molecular characterization of non-B HIV type 1 subtypes and potential impact on susceptibility to antiretroviral drugs [J].

Fleury, H ;

Recordon-Pinson, P ;

Caumont, A ;

Faure, M ;

Roques, P ;

Plantier, JC ;

Couturier, E ;

Dormont, D ;

Masquelier, B ;

Simon, F .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 2003, 19 (01) :41-47

[9] Candidate HIV/AIDS vaccines: lessons learned from the World's first phase III efficacy trials [J].

Francis, DP ;

Heyward, WL ;

Popovic, V ;

Orozco-Cronin, P ;

Orelind, K ;

Gee, C ;

Hirsch, A ;

Ippolito, T ;

Luck, A ;

Longhi, M ;

Gulati, V ;

Winslow, N ;

Gurwith, M ;

Sinangil, F ;

Berman, PW .

AIDS, 2003, 17 (02) :147-156

[10] Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy [J].

Frater, AJ ;

Dunn, DT ;

Beardall, AJ ;

Ariyoshi, K ;

Clarke, JR ;

McClure, MO ;

Weber, JN .

AIDS, 2002, 16 (08) :1139-1146

← 1 2 3 4 5 →